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The adoption of deep learning in healthcare is hindered by their “black box” nature.
In this paper, we explore the RETAIN architecture for the task of glusose forecasting
for diabetic people. By using a two-level attention mechanism, the recurrent-neural-
network-based RETAIN model is interpretable. We evaluate the RETAIN model on
the type-2 IDIAB and the type-1 OhioT1DM datasets by comparing its statistical and
clinical performances against two deep models and three models based on decision trees.
We show that the RETAIN model offers a very good compromise between accuracy
and interpretability, being almost as accurate as the LSTM and FCN models while
remaining interpretable. We show the usefulness of its interpretable nature by analyzing
the contribution of each variable to the final prediction. It revealed that signal values
older than one hour are not used by the RETAIN model for the 30-minutes ahead of time
prediction of glucose. Also, we show how the RETAIN model changes its behavior upon
the arrival of an event such as carbohydrate intakes or insulin infusions. In particular,
it showed that the patient’s state before the event is particularily important for the
prediction. Overall the RETAIN model, thanks to its interpretability, seems to be a very
promissing model for regression or classification tasks in healthcare.
Keywords: deep learning;interpretability; recurrent neural networks; attention; glucose
prediction;diabetes
1. Introduction
One of the major obstacles to the adoption of deep learning in the medical field is
the lack of interpretability of models, often characterized as “black boxes” 4. This
need for interpretability can be explained by several distinct reasons 1. The main
reason is undoubtedly the need to understand the decisions made by the models
in order to be able to trust them. This need is increased when the predictions are
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unexpected and may threaten the life of the patient. Indeed, although statistically
verified, a decision may be the result of a bias of the model in the training data. For
example, by training a model predicting the probability of death of patients from
pneumonia, Ba et al. showed that their model associated asthma patients with a
low probability of death 2. This erroneous association made by the model came
from a bias in the training data. Indeed, asthma patients are often treated first
in hospitals, resulting in low statistical mortality. The second reason behind the
need for interpretable models is that they can improve our general knowledge of
pathologies.
In general, interpretable models, such as linear regression or decision trees, per-
form poorly in comparison with more complex models. This increased complexity,
associated with a gain in performance, very often leads to a large drop in inter-
pretability (e.g., deep neural networks, random forests). Thus, recent endeavors
have been focused on how to interpret complex models, and in particular, deep
models. Among these efforts, we can identify two different approaches. The first one
aims to measure, visualize, the importance of the input data on the predictions. For
example, Simonyan et al. proposed the construction of a saliency map that identifies
the important pixels for the classification of images 27. These saliency maps were
used by Ma et al. to analyze the nature of adversarial attacks on a convolutional
network trained on medical images 19. In their work, Lundberg et al. proposed a
framework aiming to measure the importance of each input feature on the predic-
tions 17, with its application for the prevention of hypoxemia during surgeries 18.
Rather than proposing methods for interpreting black boxes, a large number of
researchers are looking at architectural modifications making deep models directly
more interpretable. Among these new architectures, the most notable are based on
the innovative mechanism of attention. It was introduced by Bahdanau et al. in
the field of machine translation 3 and then used in the Transformer architecture 30.
Thanks to the attention mechanism, models based on the Transformer architecture
are today the models obtaining the best results for all tasks relating to automatic
language processing. Built for models using sequential data, the principle of atten-
tion allows the model to focus on one or more parts of the sequence in order to
make its prediction. Allowing to obtain equal or even better performance in certain
fields, the attention paid by the model to the different temporal instants is quantifi-
able, improving the interpretability of the model. The general attention mechanism
has many variants, such as the Transformer’s multi-head attention or the two-level
attention of the RETAIN model. The latter was proposed by Choi et al. in order
to process and analyze electronic health records 5. Its temporal attention coupled
with its attention to the variable allows it to directly quantify the contribution of
each variable, at each moment, to the final prediction.
In this paper we explore the use of the RETAIN architecture and the atten-
tion mechanism for the forecasting of future glucose values for diabetic people.
These people have difficulties regulating their blood glucose level because of the
non-production of insulin by their pancreas (type-1 diabetes) or because of the in-
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creasing body resistance to its action (type-2 diabetes). Predicting future glucose
values can help them avoid short-term (e.g., coma) and long-term (e.g., cardiovascu-
lar diseases) complications induced by hypoglycemia (glucose level below 70 mg/dL)
and hyperglycemia (glucose level above 180 mg/dL). Thanks to the increasing avail-
ability of diabetes-related data, the field of glucose prediction has moves away from
traditionnal simple autoregressive models 28 to more complex machine learning or
deep learning models. In particular, recurrent neural networks have recently gener-
ated a lot of interest because of their temporal nature, making them particularily
suitable for the task of predicting future glucose values 24,29,21,?. As time-series can
be seen as one-dimension images, convolutional neural networks, which are very
popular in the image recognition community, have also been tried out for the fore-
casting of future glucose values with very promissing results 31,16,9. While these
models are more accurate, they are also less interpretable. Interpretability is very
important in healthcare fields and especially in glucose prediction. Indeed, it allows
the patient to make more informed decisions based on the model’s predictions (e.g.,
why is the model predicting a future hypoglycemia?). Also this can improve the
understanding of the individual specificities of the disease by either him/her or the
doctor. Finally, it can help the scientist in the construction of the model, whether
in its architecture or in the nature of the data used. While not fully interpretable,
some researchers explored the use of decision-tree based models such as random
forests or gradient boosting machines 23,12,22.
Our contributions are the following:
• The RETAIN architecture has initially been proposed in the context of
heart failure detection from electronic health records. As this is a classifi-
cation task, we adapted the framework for regression problems. We further
improve the interpretability of the model by proposing a new metric, the
absolute normalized contribution of input variables on the prediction. Com-
pared to the standard contribution metric, it enables the use of statistical
tools for the analysis of the model’s behavior.
• We demonstrate empirically the interest of the RETAIN model by apply-
ing it to the challenging task of glucose forecasting for diabetic people. For
this purpose we used two different datasets, namely the IDIAB dataset and
the OhioT1DM dataset. While the OhioT1DM dataset has been released
by Marling et al. 20 and is made of 6 type-1 diabetic people, the IDIAB
dataset has been collected by ourseleves and comprises 6 type-2 diabetic
patients. We compared the statistical and clinical performances of the RE-
TAIN model against several reference models including deep models and
decision-tree-based models. Finally, we demonstrate the usefullness of the
interpretability of the RETAIN model by analyzing its behavior predicting
future glucose values.
• Compared to our previous publication on the topic 8, we strengthened the
evaluation by adding another dataset, by adding several other reference
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models, and by personalizing all the models to the diabetic patient.
• We open-sourced the source code of this study in a GitHub repository 7.
It includes the whole data pipeline and the implementation of the models.
This paper is organized as follows. First, we present the attention mechanism,
the RETAIN architecture as well as the process of interpreting its predictions.
After having detailed the general methodology that was followed in this study, we
present the experimental results of the models. Finally, we empirically demonstrate
the interest of the RETAIN architecture through various visualization tools for
blood glucose prediction.
2. The Attention Mechanism and the RETAIN Architecture
This section introduces the attention mechanism and the RETAIN architecture with
its two-level attention and the computation of the input variables contribution to
the predictions.
2.1. Presentation of the Attention Mechanism for Regression
Problems
Before describing the RETAIN architecture, we propose to lay the foundations of
the attention mechanism applied to regression tasks. The attention mechanism was
first introduced in the field of machine translation by Bahdanau et al. 3. This field
is characterized by the use of sequential multi-input multi-output architectures,
the input and output data being represented by vectors of words forming sentences
(e.g., translation of a sentence in French into a sentence in English). On the other
hand, most regression tasks have only one output resulting in a simplification of
the architecture implementing the attention mechanism 26.
In the following paragraphs, supported by Figure 1, we proceed to describ the
architecture of a recurrent neural network implementing the standard attention
mechanism. This model aims at predicting the value yt+PH from the input data
xt−H , ...,xt, where xi ∈ Rr, i ∈ [t−H, t] and H represents the length of the input
sequence.
First, according to Equation 1, a recurrent neural network RNN transforms the
input data into hidden representations hi ∈ Rp, where p is the number of neurons
(or LSTM units for instance) of the recurrent neural network.
ht−H , ...,ht = RNN(xt−H , ...,xt) (1)
From the hidden representations hi, the attention weights αi ∈ R can be com-
puted according to Equation 2. Equation 2a implements a dense layer of neurons
(weights wα ∈ Rp and bias bα ∈ R) to compute the relative attention ei ∈ R
of each hidden representation. These attention weights are then normalized into
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Fig. 1: Recurrent neural network using the standard attention mechanism.
αi through the Softmax operation described by Equation 2b. This normalization
guarantees attention weights between 0 and 1 and whose sum equals 1.
ei = w
T
αhi + b (2a)
αi =
exp (ei)∑t
j=t−H exp (ej)
(2b)
Then, according to Equation 3, the context vector ct ∈ Rp is computed as the
sum of the hidden representations hi weighted by their respective attention weight
αi.
ct =
t∑
i=t−H
αihi (3)
Finally, according to Equation 4, the model prediction can be computed by a
dense layer of neurons (weights wout ∈ Rp and bias bout ∈ R) taking as input the
context vector ct.
yˆt+PH = w
T
outct + bout (4)
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In comparison with a standard recurrent-neural-network-based architecture, this
architecture weights the hidden representations hi by the attention weights αi. This
incentivizes the last hidden layer to prioritize the temporal instants according to
their importance. Furthermore, it is possible to analyze the attention weights in
order to identify the important temporal instants in the prediction process. This
particularity allows the attention-based model to be more interpretable than a
standard model.
2.2. Presentation of the RETAIN Architecture
Although the standard attention-based architecture allows some interpretability of
the predictions, it still limited. Indeed, it is not possible to evaluate the impor-
tance of the input variables within a precise instant. This limitation comes from
the computation of the hidden representation which is computed by a RNN. As
a RNN is a non-linear model (e.g., with LSTM cells), it is non-interpretable. To
overcome this limitation, Choi et al. proposed the RETAIN architecture 5. It sepa-
rates the computation of the attention weights from the computation of the hidden
representations. While the computation of attention weights is done with a recur-
rent neural network, the hidden representations are computed with a dense linear
layer. In addition, a second recurrent neural network has been added to the RE-
TAIN architecture to compute a second level of attention. This new attention is
paid to the variable, thus allowing the model to focus on particular input variables
within a specific instant. Once the attention weights have been determined, the
computation of the predictions is done in a linear fashion. This makes it possible
to measures the contribution of the input variables at each instant to the final pre-
diction. The RETAIN model nonetheless remains a non-linear model thanks to the
computation of attention weights being done in a non-linear way through the use
of recurrent neural networks. The measurement of the contribution of each variable
at each instant makes the RETAIN architecture much more interpretable than an
architecture implementing the standard attention mechanism.
The predictions of the RETAIN model are made in 5 steps, of which Figure 2
gives a graphical representation. As before, xt ∈ Rr represents the r input variables
at time t. The set of input data is represented by xt−H , ...,xt where H represents
the length of the history known by the model.
Step 1: First of all, for each time instant i, i ∈ [t, t−H], hidden representations,
also refered as embeddings in the original publication, vi ∈ Rm are computed from
the input data by the linear operation described by Step 1 . While m represents
the size of the hidden representations, W emb ∈ Rm×r is the matrix allowing their
computation.
vi = W embxi (Step 1)
Step 2: These hidden representations are given as input to a first recurrent
neural network RNNα of p neurons (Step 2.1, with gi ∈ Rp), followed by a linear
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Fig. 2: Graphical representation of the RETAIN model. Step 1: The input sig-
nals are transformed into hidden representations. Step 2: The weights related to
temporal attention are computed from the hidden representations. Step 3: The
weights related to the attention to the variable are also computed from the hidden
representations. Step 4: The context vector is computed from the hidden repre-
sentations weighed by the attention weights. Step 5: The prediction is made from
the context vector.
layer (Step 2.2, with wα ∈ Rp and bα ∈ R) and Softmax normalization (Step 2.3)
to compute the temporal attention weights αi ∈ R. They represent the weights
(positive, between 0 and 1) that the model will give at each instant i within the
history to the hidden representations of the input variables. The greater the weights,
the more the given instant will be taken into account in the final computation of
the prediction.
gt−H , ..., gt = RNNα(vt−H , ...,vt) (Step 2.1)
ei = w
T
αgi + bα (Step 2.2)
αt−H , ..., αt = Softmax(et−H , ..., et) (Step 2.3)
Step 3: Simultaneously, the features extracted in Step 1 are also given as input
to a second recurrent neural network RNNβ of q neurons (Step 3.1). Its output,
hi ∈ Rq, is used to compute the variable-level attention weights βi ∈ Rm (Step
3.2, with W β ∈ Rm×q and bβ ∈ Rm). The use of the activation function tanh
enables a positive and negative weighing, between -1 and 1, of the impact of the
different embeddings from a given instant. Although the attention weights to the
variable βi are directly linked to the hidden representations vi (see Figure 2), we
can infer the attention to the variables xi thanks to the linearity of the computation
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of the hidden representations vi.
ht−H , ...,ht = RNNβ(vt−H , ...,vt) (Step 3.1)
βi = tanh(W βhi + bβ) (Step 3.2)
Step 4: The context vector ct ∈ Rm is computed as the sum, on the time axis,
of the features vi weighted by their temporal attention αi and their attentions to
the variable βi (see Step 4).
ct =
t∑
i=t−H
αiβi  vi (Step 4)
Step 5: Finally, the prediction yˆt+PH is computed by a linear dense layer ac-
cording to Step 5, where wout ∈ Rm and bout ∈ R. After computing the predictions,
like any neural network, the model can adjust its different weights (W emb, RNNα,
RNNβ , wα, W β and wout) by back-propagating the gradient error (e.g., mean-
squared error).
yˆt+PH = w
T
outct + bout (Step 5)
Differences with the RETAIN model of Choi et al.: The RETAIN model
was initially proposed for classification tasks (e.g., detection of heart failure), tasks
that are different from regression ones. Thus, we have adapted it, through Step 5,
for regression tasks.
Furthermore, in its version published by Choi et al., The recurrent neural net-
works RNNα and RNNβ process the temporal instants t −H to t in the opposite
direction of time. According to the authors, this allows the model to mimic the
analysis of doctors looking first on recent consultations. Our experiments did not
seem to benefit from the compution of the attention weights in the opposite di-
rection of time. Thus, we suppose that this is not a essential part of the RETAIN
architecture and should be customized according to the task at hand a.
2.3. How to Interpret the RETAIN Architecture
2.3.1. Contribution of the input variables on the final prediction
The coefficients αi and βi represent the weights of past temporal instants and the
weights of the hidden representations vi in the computation of the final prediction.
Thanks to its almost-linear structure, we can compute the contribution of each
aThe name of RETAIN means REverse Time AttentIoN. Not computing the attention weights in
reverse time order makes the name of RETAIN not very adequate. Nonetheless, we have kept it
to give credit to the authors.
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input variable to the prediction made by the RETAIN architecture. The Equation 7
allows to express, from the Equation Step 5, the computation of the final prediction
yˆt+PH from the input variables xi, the attentions αi and βi, the matrix computing
the embeddings W emb, and the one computing the final prediction wout with its
associated bias bout.
yˆt+PH = w
T
outct + bout (7a)
= wTout(
t∑
i=t−H
αiβi  vi) + bout (7b)
= wTout(
t∑
i=t−H
αiβi  (W embxi)) + bout (7c)
Equation 8 gives the rewriting of the embeddings vi as the sum over j of the
input variables xi,j , j ∈ [1, r] weighted by the j-th column of the matrix W emb,
W emb[:, j].
vi = W embxi (8a)
=
r∑
j=1
xi,jW emb[:, j] (8b)
Starting from Equation 7c, the computation of the final prediction yˆt+PH can
thus be rearranged according to Equation 9.
yˆt+PH = w
T
out(
t∑
i=t−H
αiβi  (
r∑
j=1
xi,jW emb[:, j])) + bout (9a)
=
t∑
i=t−H
r∑
j=1
wTout(αiβi  (xi,jW emb[:, j])) + bout (9b)
=
t∑
i=t−H
r∑
j=1
xi,jαiw
T
out(βi W emb[:, j]) + bout (9c)
This rearrangement shows that the final prediction yˆt+PH is a linear combina-
tion of the input variables xi,j . Thus, Equation 10 allows us to give a definition of
the contribution, ω(yˆt+PH , xi,j), of j-th variable at time i on the prediction yˆt+PH .
ω(yˆt+PH , xi,j) = αiw
T
out(βi W emb[:, j])︸ ︷︷ ︸
contribution coefficient
xi,j︸︷︷︸
input variable
(10)
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2.3.2. Absolute normalized contribution
The contribution w(yˆt+PH , xi,j) of the input variable xi,j on the prediction yˆt+PH
makes it possible to analyze the behavior and reasoning of the model in the com-
putation of the final predictions. However, this value is not practical for doing
statistical analysis of the average behavior of the model. First, a variable can have
a negative or a positive contribution depending on the situation. Thus, the compu-
tation of the average contribution of such a variable may not be representative of its
real impact on the predictions. Also, the contribution of an input variable depends
on the amplitude of the prediction. Therefore, all the samples are not given the
same importance in the computation of the mean contribution of an input variable
to the prediction, giving more importance to high amplitude predictions. To address
these limits, we propose the absolute normalized contribution, ωAN (yˆt+PH , xi,j),
of the input variable xi,j on the prediction yˆt+PH . Described by Equation 11, it
allows to measure, between 0 and 1, the absolute amplitude of the contribution of
the input variable xi,j on the prediction yˆt+PH .
ωAN (yˆt+PH , xi,j) =
|ω(yˆt+PH , xi,j)|∑t
i=t−H
∑r
j=1 |ω(yˆt+PH , xi,j)|
(11)
3. Methods
In this paper, we study the RETAIN model for the task of predicting future glucose
values of diabetic people, task that can be described as a regression problem. From
past glucose values and other information such as insulin infusions or carbohydrate
(CHO) intakes, the model tries to predict the patient’s future glucose values, usually
between 15 to 120 minutes ahead of time 25.
In the section, we present the methodology that has been carried out to evaluate
the RETAIN model in the context of glucose forecasting for diabetic people. First,
we describe the two datasets that have been used in the study. Then, we provide the
details of the implementation of the RETAIN model as well as the implementation
of the reference models. Finally, we report the post-processing steps and evaluation
metrics that we used.
3.1. Experimental Data
3.1.1. IDIAB Dataset (I)
The IDIAB dataset has been collected by ourselves on 6 type-2 diabetic patients
(5F/1M, age 56.5 ± 9.14 years old, BMI 33.52 ± 4.17 kg/m2). The data collec-
tion has been approved by the French ethical commitee (ID RCB 2018-A00312-53).
The patients had been monitored for 31.17 ± 1.86 days in free-living conditions.
While glucose values (in mg/dL) have been collected using FreeStyle Libre contin-
uous glucose monitoring devices (Abbott Diabetes Care), CHO intakes (in g) and
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insulin infusion values (in unit) have been obtained through the mySugr coaching
application for diabetes.
3.1.2. OhioT1DM Dataset (O)
The OhioT1DM dataset has been released by Marling et al. for the Blood Glucose
Level Prediction Challenge 20. It is made of data coming from 6 type-1 diabetic
patients (2M/4F, age between 40 and 60 years old, BMI not disclosed) that had
been monitored for 8 weeks in free living conditions. To be consistent with the
IDIAB dataset, in this study we only use the most important signals which are the
glucose values, the insulin infusions, and the CHO intakes.
3.2. Preprocessing
In order to train the models efficiently, a few preprocessing steps must be carried
out. Figure 3 gives a graphical representation of these steps. These steps are similar
to the benchmark study we conducted 6.
Preprocessing
Files
Loading Cleaning
Samples
Creation
Recovering
Missing
Data
Splitting
Feature
Scaling
history
length
prediction
horizon
sampling
frequency
cross-validation
factor
time-series time-series samples samples cv. folds train. folds
valid. folds
test. folds
scaler mean
and std
Fig. 3: Preprocessing of the data.
3.2.1. Cleaning
The graphical analysis of glucose data from the IDIAB dataset revealed some values
that appear to be erroneous. These values are characterized by peaks in blood sugar
that last only for one sample (unlike the gradual increase in blood sugar following
the ingestion of carbohydrates). The amount of erroneous values varies from patient
to patient. Keeping them would bias the training of predictive models as well as
their evaluation. Therefore, we chose to remove these values from the signals.
3.2.2. Samples Creation
In order to create the training samples from the glucose, CHO, and insulin signals,
we need to resample them to the same sample frequency. We chose to resample the
time-series to one sample every 5 minutes, which is the sampling frequency of the
OhioT1DM glucose signal.
A training sample can be expressed as the set {Xt, yt+PH}, where Xt =
xt−H , ...,xt with xi, i ∈ [t − H,H] being the input data at step i, and where
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yt+PH is the objective glucose value at horizon PH. In this study, we focus on a
30 minutes prediction horizon, as it is the most used one. As for the input values
Xt, they are made of the 3-hour history of glucose, CHO, and insulin values.
3.2.3. Recovering Missing Data
There are a lot of missing glucose values in both datasets coming from sensors
or human errors. Moreover, the upsampling of the IDIAB glucose signal (from 15
minutes to 5 minutes) has also introduced a lot of missing values. Some of these
values can be artificially recovered by following the following strategy for each
sample:
(1) linearly interpolate the glucose history when the missing value is surrounded
by two known glucose values;
(2) extrapolate linearly in the opposite case, usually when the missing glucose value
is the most recent data;
(3) discard samples when the ground truth yt+PH is not known to prevent training
on artificial data.
3.2.4. Splitting
The OhioT1DM is originally split into training and testing sets, the testing set
accounting for the last 10 days of each patient. As the IDIAB has around half as
much of data, its testing sets are made of the last 5 days for each patient.
Then, every training set is split into a training and validation set following a
80%/20% distribution. The validation sets are used as a prior evaluation of the
models when optimizing their hyperparameters. That way, the testing sets are only
used for the final evaluation.
3.2.5. Standardization
As it is common practice in the machine-learning community, the data have been
standardized (zero mean and unit variance) w.r.t. their training set.
3.3. Glucose Predictive Models
We present here the different glucose predictive models used in this study: the
RETAIN model, the two deep reference models LSTM and FCN, as well as DT,
RF and GBM, three reference models based on decision trees.
3.3.1. Multi-Source Adversarial Transfer Learning
To account for the high inter and intra variability of the diabetic population, glucose
predictive models need to be personalized the patient 25. However, this reduces
considerably the amount of data available, hurting the training of the models. In a
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previous study of ours, we showed that deep models in particular suffer from the
lack of data as they are very prompt to overfit the training data 6. To alleviate
this burden, we proposed in a previous study the multi-source adversarial transfer
learning framework (ATL) 9. In the ATL setting, a first model is trained on source
patients, and then finetuned to the target patient. While the target patient is the
patient we want the model to be personalized to, the source patients are several
patients different from the target patient. To ensure that the first model trained
on the source patients generalizes well, easing the transfer to the target patient,
we add an adversarial module to the initial model. Taking as input the hidden
representations of the input data computed by the model, the module tries to
identify the patient of origin of the given sample. When training the classifier,
back-propagating the loss into the whole network, the gradient is multiplied by -1
when arriving to the computation of the hidden representation. Overall, adding
the adversarial module ensures the computation of a feature representation that is
useful to the task of glucose prediction but that is also patient agnostic.
As it showed to significatively improve the accuracy of the present FCN model in
our previous study, we decided to use the methodology to the LSTM and RETAIN
models. In particular, we consider the intra-dataset transfer type, having the source
patients being from the same dataset as the target patient. During the training
on the source patients, Equation 12 expresses the loss function as the weighted
combination of the mean-squared error (used for the prediction of glucose) and the
multi-class cross-entropy (for the patient classification). In this equation, while λ
balances the importance of the two objectives, yg,yp, yˆg, yˆp are respectively the
glucose and patient ground truths, and the glucose and patient predictions.
Loss(yg,yp, yˆg, yˆp) = MSE(yg, yˆg) + λ · Cross-Entropy(yp, yˆp) (12)
As for the other reference models based on decision trees, as they are not neural
networks, we could not use the transfer learning methodology. As a consequence,
these models are directly trained on the individual patients.
3.3.2. RETAIN model
The RETAIN architecture has three different elements to configure: the dimen-
sion of the extracted features vi and the sizes and natures of the recurrent neural
networks RNNα and RNNβ . After a grid search on the validation set, we chose a
feature dimension of 64 as well as recurrent networks of LSTM nature with a single
layer of 128 units.
In order to implement the multi-source adversarial transfer learning methodol-
ogy, we have added to the RETAIN architecture a patient classifier module. It has
been positioned after the computation of the context vector ct which represents
the final hidden representation used for the prediction. Symmetrically with the
computation of the glucose prediction being done with a dense layer, the patient
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classification is done with a dense layer followed by a Softmax normalization. This
allows the patient classifier module to be trained to minimize multi-class cross-
entropy, the error gradient of which is reversed when arriving at the computation
of the context vector.
The training of the RETAIN model was done using the Adam optimizer and
by mini-batch of 50 samples. The overall learning rate was 10−3 when training on
the source patients, then 10−4 when finetuning the model on the target patient.
To avoid overfitting the model to training data, the early stopping methodology
was used with a patience of 100 epochs when training on source patients and 25
epochs when finetuning to the target patient. Finally, the coefficient λ was 10−2.5,
maximizing the MSE obtained after transfer on the validation set of the target
patient.
3.3.3. Deep reference models
The RETAIN model uses LSTM recurrent neural networks to calculate attention
weights. In order to evaluate the performances linked to this particular use of the
LSTM network, we can use a standard LSTM model. Like the RETAIN model, the
LSTM model can use the adverse transfer learning. For this, we can link the hidden
representation of the network, usually linked to a dense layer to make the glucose
prediction, to a second parallel dense layer performing the patients classification.
Similarly, the patient classifier is trained to minimize multi-class cross-entropy, the
error gradient of which is reversed upon arriving at the LSTM network. In this
study, we use the architecture and training hyperparameters of the LSTM model of
the benchmark study we conducted 6. It consists of two layers of 256 LSTM units.
It is trained with the Adam optimizer by mini-batch of 50 samples with a learning
rate of 10−3 during training on source patients, and of 10−4 during finetuning
on the target patient. A L2 regularization of 10−4 as well as the early stopping
methodology (patience of 100 epochs while learning on the source patients, then 25
on the target patient) were used to limit the overfitting of the model. Finally, as for
the RETAIN model, the gradient of the error linked to the multi-class cross-entropy
of the patient classifier is weighted by λ = 10−2.5.
Also, we include the FCN model that has been used when studying the multi-
source adversarial transfer learning methodology 9. The hidden representation is
computed by 3 convolutional layers (1-dimensional convolution of size 3 → ReLU
activation function → batch normalization → dropout) with 64, 128, and 64 chan-
nels respectively. From the hidden representation, the glucose prediction is com-
puted as a dense layer of 2048 neurons and the patient probability distribution is
computed with another parallel dense layer of 2048 neurons. The FCN has been
trained with the Adam optimizer by mini-batch of size 100, a learning of 10−4 when
training on the source patients and of 10−5 during finetuning. For regularisation,
we used a dropout rate of 50% and the early stopping methodology (patience of
250 first, and then 50). The MSE and cross-entropy losses have been weighted by
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λ = 10−0.75.
3.3.4. Reference models based on decision trees
In order to evaluate the performances of the RETAIN model, we also chose to
compare it with a simple but interpretable decision tree (DT) model. We complete
this model with two other models, random forests (RF) and gradient boosting
machines (GBM), both based on sets of decision trees. The RF and GBM models
are generally more efficient than simple decision trees thanks to their complexity.
While this performance gain comes with a drop in interpretability, these models
are still more interpretable than most machine learning models by being able to
measure the Gini importance of the input variables. For a single tree, the Gini
importance of an input variable is computed as the drop in impurity by the node
making the decision on this variable, weighted by the probability of reaching the
node. For an RF or GBM model, the importance of the variables is averaged over
the entire forest.
The DT model is a standard decision tree. Although simple in nature, decision
trees have been used several times for the blood glucose prediction task 22,15. When
creating the tree, in order to reduce the impact of overfitting on training data, we
can constrain a branch separation to have a minimum number of training sam-
ples supporting this separation. This number has been set at 100 for the IDIAB
dataset and 500 for the OhioT1DM dataset. This difference can be explained by a
higher total number of training samples for the OhioT1DM dataset, thus allowing
a stronger constraint on the branch separation.
The random forest (RF) model, is an ensemble model based on decision trees.
It is composed of a large number of decision trees, each tree being different from
the others thanks to a randomization process used during their creation. This ran-
domization affects both the input variables used when creating new branches, but
also the selection of samples used for their creation. This randomization encourages
diversity within the forest, allowing the final prediction, computed as the average
of the individual decisions, to be more accurate. More efficient than traditional
decision trees, randomized forests are increasingly being used for the task of blood
glucose prediction 23,12,22,11. In this study, we used a forest of 100 trees. As for
the DT model, we optimized by grid search the constraint of the minimum number
of samples for having branch separation. This value was set to 50 and 250 sam-
ples for the IDIAB and OhioT1DM sets respectively. We note that these values
are lower than for the DT model. This is intuitively explained by a lower need for
regularization, which is already partly performed by the forest creation mechanism.
The GBM model is built around the gradient boosting technique. Iteratively,
decision trees are created, each tree having the objective of reducing the errors
of the previously created trees. This method differs from random forests where
trees are created simultaneously. Like random forests, models based on gradient
boosting (e.g., GBM, XGBoost) are also increasingly used in the field of blood
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glucose prediction : 23,12,22. As for the DT and RF models, we have optimized the
minimum number of samples required to create new branches to 250 and 2000 for
the IDIAB and OhioT1DM datasets respectively. These significantly higher values
induce shallower trees, which is common for GBM models. During the iterative
creation of the trees, the contribution of each tree to the final prediction is decreased
by a coefficient called the learning rate. In this study, we optimized the learning
rate to a value of 10−1. Also, we stopped the training after 10 iterations without
performance improvement on the validation subset. This method is similar to the
early stopping method used in deep learning.
3.4. Evaluation of the predictive models
Post-processing for every paired fold
Rescaling Reshaping Evaluation
predictions
ground truths
RMSE
MAPE
CG-EGA
scaler mean
and std
sampling
frequency
sampling
frequency
prediction
horizon
predictions
ground
truths
predictions
ground
truths
Fig. 4: Post-processing et evaluation of the predictions.
The evaluation of the predictive models is done following the steps described
by Figure 4. In this study we focus on the 30-minutes prediction horizon. Before
evaluating the predictions, we follow two post-processing steps. First, we rescale
the predictions to their original scale (see the features scaling preprocessing step).
Then, we reconstruct the prediction time-series by reordering the predictions.
To evaluate the models we use three different metrics: the RMSE, the MAPE,
and the CG-EGA. For each metric, the performances are averaged over the 5 test
subsets of each patient linked to the 5-fold cross-validation, then all the patients
of the same data set. Both the RMSE and MAPE metrics give a complementary
measure of the accuracy of the prediction. While the RMSE is closely related to
the actuel prediction scale, the MAPE is scale independent and is expressed in
percentage. On the other hand, the CG-EGA measures the clinical acceptability of
the prediction by analyzing the clinical accuracy as well as the coherence between
successive predictions 13. In the end, the CG-EGA classifies a prediction either as an
accurate prediction (AP), a benign error (BE), or an erroneous prediction (EP). A
high AP rate and a low EP rate are necessary for a model to be clinically acceptable.
The rates can be either averaged over all the test samples, or for the samples within
a specific glycemic region (i.e., hypoglycemia, euglycemia and hyperglycemia).
4. Results & Discussion
In this section, we first present the statistical and clinical results of the various
models we presented. Then, we analyze and interpret the predictions made by the
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RETAIN model.
4.1. Presentation of the experimental results
Table 1: Mean (with standard deviation) of statistical accuracy (RMSE and MAPE)
and general clinical acceptability (CG-EGA) for a prediction horizon of 30 minutes
and for the IDIAB and OhioT1DM datasets.
Model RMSE MAPE
CG-EGA (general)
AP BE EP
IDIAB dataset
DT 24.45 (6.69) 11.44 (1.58) 88.18 (4.87) 8.38 (2.77) 3.44 (2.38)
RF 22.35 (6.33) 10.33 (1.50) 92.15 (4.51) 4.76 (2.70) 3.09 (2.12)
GBM 21.97 (6.13) 10.13 (1.60) 91.80 (4.29) 5.05 (2.53) 3.15 (2.13)
LSTM 19.27 (5.93) 8.66 (1.00) 92.12 (2.90) 5.57 (1.56) 2.31 (1.69)
FCN 18.51 (5.48) 8.44 (1.07) 92.23 (3.57) 5.27 (2.09) 2.50 (2.00)
RETAIN 19.49 (5.69) 8.71 (0.75) 92.41 (2.94) 5.15 (1.60) 2.43 (1.58)
OhioT1DM dataset
DT 23.87 (2.28) 11.22 (2.54) 79.07 (3.92) 16.81 (2.40) 4.12 (2.13)
RF 22.03 (2.41) 10.14 (2.38) 83.67 (4.01) 11.89 (2.22) 4.44 (2.28)
GBM 21.43 (2.35) 9.78 (2.48) 83.09 (3.85) 12.07 (1.82) 4.84 (2.38)
LSTM 19.68 (2.45) 8.81 (2.23) 79.37 (4.51) 15.61 (3.33) 5.02 (1.96)
FCN 19.27 (1.78) 8.68 (1.97) 78.73 (4.59) 15.96 (3.04) 5.31 (2.17)
RETAIN 20.29 (2.40) 9.16 (2.24) 80.98 (4.84) 14.28 (3.22) 4.74 (2.17)
AP: Accurate Prediction; BE: Benign Error; EP: Erroneous Prediction
Table 1 presents the mean precision (RMSE and MAPE) as well as the general
clinical acceptability (general CG-EGA) of the models DT, RF, GBM, LSTM, FCN
and RETAIN for the IDIAB and OhioT1DM datasets. Table 2 details, for each
glycemic region, the clinical acceptability of the models (CG-EGA by region).
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First of all, within the reference models based on decision trees (DT, RF, and
GBM), we can observe the low precision and clinical acceptability of the DT model
in comparison with the RF and GBM models. This is not surprising and is explained
by the simplicity of a simple decision tree. Between the RF and GBM models,
the GBM model has a better statistical accuracy (RMSE and MAPE) but also
a poorer clinical acceptability (AP, BE and EP scores for all regions of the CG-
EGA). Overall, the results for the DT, RF and GBM models are similar for the two
datasets. The very good scores in benign BE error percentages of the RF model show
that it is capable of producing successive predictions that are consistent with each
other. Indeed, a prediction is characterized as BE when it is clinically sufficiently
accurate, but the rate of change from the previous prediction is not. A model with
a high BE rate is generally a model showing high amplitude oscillations in its
successive predictions.
As for the deep reference models LSTM and FCN, they show performances
(precision and clinical acceptability) highly superior to the models based on decision
trees. Only the clinical acceptability in the region of euglycemia and hyperglycemia
for the OhioT1DM game is less good than the ones of the RF and GBM models
(lower AP and higher EP rates). We note that the performance of the LSTM model
in this study improved upo,n the LSTM results of our benchmark study 6. This
improvement in accuracy comes from the use of the multi-source adversarial transfer
learning methodology.
The RETAIN model shows a compromise between accuracy and interpretabil-
ity. Indeed, the it is clearly more accurate than models based on decision trees
while remaining interpretable. However, its accuracy remains slightly lower than
the LSTM or FCN models. We can attribute this difference to the relative simplic-
ity of the computation of the prediction by RETAIN. In the RETAIN architecture,
the non-linearity of the computation resides only in the computation of the atten-
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tion weights. This forces the extracted features to keep a certain simplicity. From
the point of view of the clinical acceptability, the RETAIN model is slightly better,
if not equivalent, than the FCN and LSTM models.
4.2. Interpretability of the RETAIN model
The greatest strength of the RETAIN model lies in its interpretability. Indeed, by
measuring the contribution, it is possible to quantify the impact of each variable
to the prediction, thus lifting the veil on the reasoning of the model. Figure 5
gives an example of this ability. In this example, we see that the variables with
the greatest impact on the prediction are recent glucose readings. They have a
significant contribution up to 1 hour in the past (1 hour history). When it comes
to the CHO intakes and insulin injections, we can see contribution peaks when
they appear. At these same times, the contribution of the glucose signal is close
to zero. This is made possible by the attention to the variable βi computed by
RNNβ . Indeed, the sole presence of the temporal attention αi computed by RNNα
would not have made it possible to attribute a strong contribution to insulin or
carbohydrate signals and simultaneously a weak contribution to the glucose signal.
Finally, on this example, we can note that the contribution of variables older than
one hour is close to zero.
We can use the mean and maximum normalized absolute contribution of each
variable at any time to assess their overall usefulness for predicting future glucose
values. While the mean contribution is used to analyze average behavior, the maxi-
mum contribution is used to assess whether a variable was useful at least once for all
test samples. Indeed, if a variable has been useful at least once, then its maximum
normalized absolute contribution will be high (equal to its usefulness). Conversely, if
a variable is not used by the model to compute the predictions, then its contribution
will be close to zero. Figures 6 and 7 respectively represent the mean and maximum
normalized absolute contribution of each variable for the IDIAB and OhioT1DM
datasets. First, we can see that the interest of each signal decreases with how old it
is. The older a variable, the less it contributes to predictions. This decrease is faster
for the CHO and or insulin signals than for the glucose signal. While the CHO and
insulin signals are no longer of interest after about 40 minutes, the glucose signal
continues to impact predictions for up to 60 minutes. Beyond 60 minutes, no vari-
able shows to be of interest for the forecasting of glucose. However, the other models
studied in previous studies of ours have shown to benefit from a history longer an
hour 6,9. This suggests that the RETAIN model is not able to efficiently use such a
long history. This limitation would explain the slightly poorer performances of the
model compared to the LSTM and FCN models. Moreover, the comparison of the
mean normalized absolute contribution of the two IDIAB and OhioT1DM datasets
through Figure 6 shows that the variables of the two datasets, despite their intrinsic
differences (type of diabetes, material and experimental protocol), behave similarly
within the RETAIN model.
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Fig. 5: Input variables of a test sample of patient 575 from the OhioT1DM set
(top) and contribution of the variables to the prediction made by the RETAIN
model (bottom).
To go further in the analysis of the contribution of each variable, we can filter
the samples of interest. For example, through Figure 8, we are interested in the
evolution of the contribution of the variables after the arrival of an event such
as an ingestion of carbohydrates or an injection of insulin. The behavior of the
model is similar both for the two types of events (CHO or insulin) and for the two
datasets (IDIAB and OhioT1DM). When the event arrives, all the variables, except
the one corresponding to the event, have a contribution of almost zero. It is rather
the moment before the event which has a strong contribution to the prediction of
glucose. Over time, although decreasing, the contribution of the moment preceding
22 De Bois, El Yacoubi, Ammi
tt-50t-100t-150
0
0.2
0.4
0.6
0.8
1
Input history [min]
M
e
a
n
a
b
s
o
lu
t
e
n
o
r
m
a
li
z
e
d
c
o
n
t
r
ib
u
t
io
n
glucose
CHO
insulin
(a) IDIAB dataset
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(b) OhioT1DM dataset
Fig. 6: Mean absolute normalized contribution of the input variables for the patients
of the IDIAB (left) and OhioT1DM (right) datasets.
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(a) IDIAB dataset
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(b) OhioT1DM dataset
Fig. 7: Maximum absolute normalized contribution of the input variables for the
patients of the IDIAB (left) and OhioT1DM (right) datasets.
the event remains strong. This suggests that, when an event related to insulin
or carbohydrate intake occurs, events that considerably modify the regulation of
the patient’s glycemia, the model takes into account the patient’s state before the
arrival of the event. After about thirty minutes, the contribution of the variables
linked to the event becomes zero, indicating that the event information is no longer
used by the model to make its predictions.
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(a) IDIAB - CHO ingestion
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(b) IDIAB - Insulin infusion
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(c) OhioT1DM - CHO ingestion
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(d) OhioT1DM - Insulin infusion
Fig. 8: Evolution of the normalized absolute contribution of variables after an
event (carbohydrate ingestion or insulin injection) averaged for the IDIAB and
OhioT1DM datasets. The contribution of the IDIAB dataset are only available
every 15 minutes due to the sampling frequency of the FreeStyle Libre glucose
monitoring device.
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5. Conclusion
In this study, we adapted the RETAIN architecture proposed by Choi et al. for
regression tasks and analyzed its use for the prediction of future glucose values in
people with diabetes. Based on neural networks, it implements a double attention
mechanism allowing it to be interpretable. This ability makes it particularly inter-
esting for biomedical tasks, and in particular for the forecasting of glucose values.
We evaluated the statistical (RMSE and MAPE) and clinical (CG-EGA) per-
formances of the RETAIN model by comparing it to decision tree-based models
and deep models. The results showed us that the models based on decision trees
are largely outclassed by deep models, and in particular by the RETAIN model. In
comparison with the LSTM and FCN models, the RETAIN model shows to have a
slightly lower accuracy but a better, or at least equal, clinical acceptability. How-
ever, the real strength of the RETAIN model lies in its interpretability. Thanks to
this ability, we carried out an analysis of the importance of the glucose, CHO and
insulin signals to the forecasting of future glucose values. This analysis showed us
that values older than one hour (history greater than one hour) are not used by
the RETAIN model. We suppose that this limitation comes from the quasi linearity
of the computation of the predictions made by the RETAIN model. We then ana-
lyzed the contribution of the input variables in the presence of an insulin infusion
or CHO intake event. Following such events, the RETAIN model adopts a different
behavior by strongly taking into account the moment preceding the event. After
30 minutes after the occurrence of the event, the RETAIN model returns to its
standard behavior.
Overall, the RETAIN model shows to be promissing for biomedical use, and
in particular for predicting future glucose values in people with diabetes. Its in-
terpretable feature is particularly interesting both for the patient but also for the
practitioners and scientists behind the creation of the model. First of all, such a
model can be useful for the therapeutic education of the patient, explaining to
him/her the impact of the variables on the regulation of his/her glycemia. In ad-
dition, the patient can also understand the reasoning behind the decisions of the
model, and adapt his/her behavior accordingly. Finally, as we have seen in this
study, the analysis of the importance of the input variables can be essential in the
design of new, more efficient architectures. These new architectures can include new
data from various origins, such as physical activity or sleep data. These new archi-
tectures can also be made more complex, in particular through more sophisticated
hidden representations while remaining interpretable. In the original RETAIN pub-
lication, the authors discuss the use of multi-layer perceptrons for the computation
of better hidden representations 5,10,14. However, this complexification of the archi-
tecture must still allow the computation of the contributions of all the variables to
the final prediction in order to not lose in interpretability.
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